Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

Develops cell therapies and tissue products for bone grafts and inflammation repair.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company specializing in regenerative medicine. The company develops investigational cell therapy and tissue engineering products to address unmet medical needs related to tissue damage, inflammation, and bone loss. Its pipeline is led by two key candidates: BonoFill, a personalized, viable bone graft engineered from a patient's own cells for orthopedic and maxillofacial applications; and MesenCure, an allogeneic cell therapy designed to target inflammation and promote tissue repair. These therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Investor Presentation
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Regulatory News Service
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Investor Presentation
Company Presentation
English 8.2 MB
2022-04-11 16:02
Registration Form
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Investor Presentation
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Pre-Annual General Meeting Information
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
Regulatory News Service
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea 310210
Voyager Therapeutics, Inc. Logo
Developing AAV gene therapies for neurological diseases like Alzheimer's, ALS, and Parkinson's.
United States of America VYGR
VS MEDIA Holdings Ltd Logo
A global media network connecting creators and brands for data-driven social commerce.
United States of America VSME
WDB coco CO.,LTD. Logo
CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.
Japan 7079
WDB HOLDINGS CO.,LTD. Logo
Provides specialized staffing, contract research (CRO) services, and related digital platforms.
Japan 2475
WEATHERNEWS INC. Logo
Global weather data & risk solutions for B2B (sea, air, land) and consumer apps.
Japan 4825

Talk to a Data Expert

Have a question? We'll get back to you promptly.